MPHMedicure Inc.
1.360CAD0.00%Mkt Cap: 10.56M $P/E:

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa recepto…

HeadlineSourceTime
This week
Medicure Inc (MCUJF) (Q2 2026) Earnings Call Highlights: Revenue Growth and Strategic Expansion ...

Medicure Inc (MCUJF) reports a 10% revenue increase to $7.4 million, driven by ZYPITAMAG and pharmacy acquisitions, despite a widened net loss from a one-time CMS assessment.

GuruFocus.com
Older
GuruFocus.com
Medicure Inc (MCUJF) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Rising Losses

Despite a significant increase in annual revenue, Medicure Inc (MCUJF) faces challenges with a net loss and strategic investments impacting financials.

GuruFocus.com
Medicure: Q3 Earnings Snapshot

WINNIPEG, Manitoba (AP) — Medicure Inc. MCUJF) on Wednesday reported a loss of $1 million in its third quarter. The Winnipeg, Manitoba-based company said it had a loss of 9 cents per share.

AAssociated Press Finance
Medicure Second Quarter 2025 Earnings: CA$0.08 loss per share (vs CA$0.12 loss in 2Q 2024)

Medicure ( CVE:MPH ) Second Quarter 2025 Results Key Financial Results Revenue: CA$6.67m (up 29% from 2Q 2024). Net...

Simply Wall St.
Medicure: Q2 Earnings Snapshot

WINNIPEG, Manitoba (AP) — Medicure Inc. MCUJF) on Wednesday reported a loss of $568,000 in its second quarter. The Winnipeg, Manitoba-based company said it had a loss of 6 cents per share.

AAssociated Press Finance